Losartan/Hydrochlorothiazide Aurobindo 50 mg/12.5 mg film-coated tablets माल्टा - अंग्रेज़ी - Medicines Authority

losartan/hydrochlorothiazide aurobindo 50 mg/12.5 mg film-coated tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, losartan potassium - film-coated tablet - hydrochlorothiazide 12.5 mg losartan potassium 50 mg - agents acting on the renin-angiotensin system

Losartan/Hydrochlorothiazide Aurobindo 100 mg/12.5 mg film-coated tablets माल्टा - अंग्रेज़ी - Medicines Authority

losartan/hydrochlorothiazide aurobindo 100 mg/12.5 mg film-coated tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, losartan potassium - film-coated tablet - hydrochlorothiazide 12.5 mg losartan potassium 100 mg - agents acting on the renin-angiotensin system

Losartan/Hydrochlorothiazide Aurobindo 100 mg/25 mg film-coated tablets माल्टा - अंग्रेज़ी - Medicines Authority

losartan/hydrochlorothiazide aurobindo 100 mg/25 mg film-coated tablets

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, losartan potassium - film-coated tablet - hydrochlorothiazide 25 mg losartan potassium 100 mg - agents acting on the renin-angiotensin system

Amizide tablet ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

amizide tablet

alphapharm pty ltd - hydrochlorothiazide, quantity: 50 mg; amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; lactose monohydrate; magnesium stearate; povidone; wheat starch - amizide is indicated in the treatment of patients with: oedema of cardiac origin; hepatic cirrhosis with ascites; hypertension in whom potassium depletion might be anticipated. amizide, with its combination of amiloride hydrochloride and hydrochlorothiazide, minimizes the possibility of the development of excessive potassium loss in patients during vigorous diuresis for prolonged periods. amizide, with it's built in potassium sparing agent, is especially indicated in those conditions where the positive effect on potassium balance is particularly important. hypertension. amizide may be used alone or as an adjunct to other anti-hypertensive drugs. since it enhances the action of these agents, the dosage of these antihypertensive drugs may need to be reduced to avoid the risk of an excessive drop in blood pressure.

Co-Amiloride Teva 5 mg - 50 mg tabl. बेल्जियम - अंग्रेज़ी - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

co-amiloride teva 5 mg - 50 mg tabl.

teva pharma belgium sa-nv - hydrochlorothiazide 50 mg; amiloride hydrochloride 5 mg - tablet - 5 - 50 mg - hydrochlorothiazide 50 mg; amiloride hydrochloride dihydrate 5.68 mg - hydrochlorothiazide and potassium-sparing agents

LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE- losartan potassium and hydrochlorothiazide tablet संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

losartan potassium and hydrochlorothiazide- losartan potassium and hydrochlorothiazide tablet

preferred pharmaceuticals, inc. - hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th), losartan potassium (unii: 3st302b24a) (losartan - unii:jms50mpo89) - hydrochlorothiazide 25 mg - losartan potassium and hydrochlorothiazide tablets usp are indicated for the treatment of hypertension. this fixed dose combination is not indicated for initial therapy of hypertension, except when the hypertension is severe enough that the value of achieving prompt blood pressure control exceeds the risk of initiating combination therapy in these patients (see clinical pharmacology, pharmacodynamics and clinical effects, and dosage and administration). losartan potassium and hydrochlorothiazide tablets usp are indicated to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy, but there is evidence that this benefit does not apply to black patients. (see precautions, race, clinical pharmacology, pharmacodynamics and clinical effects, losartan potassium, reduction in the risk of stroke, race , and dosage and administration .) losartan and hydrochlorothiazide is contraindicated in patients who are hypersensitive to any component of this product. because of the hydrochlorothia

Amiloride 5mg Tablets BP माल्टा - अंग्रेज़ी - Medicines Authority

amiloride 5mg tablets bp

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - amiloride hydrochloride - tablet - amiloride hydrochloride 5 mg - diuretics

AMILORIDE HYDROCHLORIDE TABLETS, USP कनाडा - अंग्रेज़ी - Health Canada

amiloride hydrochloride tablets, usp

orbus pharma inc - amiloride hydrochloride - tablet - 5mg - amiloride hydrochloride 5mg - potassium-sparing diuretics

AMILORIDE HYDROCHLORIDE tablet संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

amiloride hydrochloride tablet

bryant ranch prepack - amiloride hydrochloride anhydrous (unii: 7m458q65s3) (amiloride - unii:7dzo8eb0z3) - amiloride hcl is indicated as adjunctive treatment with thiazide diuretics or other kaliureticdiuretic agents in congestive heart failure or hypertension to: - help restore normal serum potassium levels in patients who develop hypokalemia on the kaliuretic diuretic. - prevent development of hypokalemia in patients who would be exposed to particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias. the use of potassium-conserving agents is often unnecessary in patients receiving diuretics for uncomplicated essential hypertension when such patients have a normal diet. amiloride hcl has little additive diuretic or antihypertensive effect when added to a thiazide diuretic. amiloride hcl should rarely be used alone. it has weak (compared with thiazides) diuretic and antihypertensive effects. used as single agents, potassium sparing diuretics, including amiloride hcl, result in an increased risk of hyperkalemia (approximately 10% with amiloride). amilo

AMILORIDE HYDROCHLORIDE tablet संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

amiloride hydrochloride tablet

sigmapharm laboratories, llc - amiloride hydrochloride anhydrous (unii: 7m458q65s3) (amiloride - unii:7dzo8eb0z3) - amiloride hcl tablets are indicated as adjunctive treatment with thiazide diuretics or other kaliureticdiuretic agents in congestive heart failure or hypertension to:                a. help restore normal serum potassium levels in patients who develop hypokalemia on the kaliuretic diuretic                b. prevent development of hypokalemia in patients who would be exposed to particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias. the use of potassium-conserving agents is often unnecessary in patients receiving diuretics for uncomplicated essential hypertension when such patients have a normal diet. amiloride hcl tablets have little additive diuretic or antihypertensive effect when added to a thiazide diuretic. amiloride hcl tablets should rarely be used alone. it has weak (compared with thiazides) diuretic and antihypertensive effects. used as single agents, potassium sparing diuretics, including amiloride hcl tablets, result in